ORCHID PHARMA
Back to Cashflow Statement
|
ORCHID PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹19 Cr | ₹126 Cr | ₹18 Cr | ₹92 Cr | ₹24 Cr |
What is the latest Cash Flow from Operating Activities ratio of ORCHID PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹126 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹92 Cr |
| Mar2021 | ₹24 Cr |
How is Cash Flow from Operating Activities of ORCHID PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | -84.75 | |
| Mar2024 | ₹126 Cr | 587.05 | |
| Mar2023 | ₹18 Cr | -80.17 | |
| Mar2022 | ₹92 Cr | 292.08 | |
| Mar2021 | ₹24 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹3,497.3 Cr | -2.9% | -11.9% | -57.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -2.9% |
-11.9% |
-57.2% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses